JP2014515747A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515747A5 JP2014515747A5 JP2014504346A JP2014504346A JP2014515747A5 JP 2014515747 A5 JP2014515747 A5 JP 2014515747A5 JP 2014504346 A JP2014504346 A JP 2014504346A JP 2014504346 A JP2014504346 A JP 2014504346A JP 2014515747 A5 JP2014515747 A5 JP 2014515747A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- seq
- oxytocin
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161475471P | 2011-04-14 | 2011-04-14 | |
| US61/475,471 | 2011-04-14 | ||
| SE1150324A SE536091C2 (sv) | 2011-04-14 | 2011-04-14 | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
| SE1150324-0 | 2011-04-14 | ||
| PCT/EP2012/056813 WO2012140216A1 (en) | 2011-04-14 | 2012-04-13 | Pharmaceutical composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014515747A JP2014515747A (ja) | 2014-07-03 |
| JP2014515747A5 true JP2014515747A5 (https=) | 2015-05-28 |
| JP5993442B2 JP5993442B2 (ja) | 2016-09-14 |
Family
ID=47008851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504346A Expired - Fee Related JP5993442B2 (ja) | 2011-04-14 | 2012-04-13 | 医薬組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9034821B2 (https=) |
| EP (1) | EP2696882B1 (https=) |
| JP (1) | JP5993442B2 (https=) |
| KR (1) | KR101940341B1 (https=) |
| CN (1) | CN103596582B (https=) |
| AU (1) | AU2012241805B2 (https=) |
| BR (1) | BR112013026153A2 (https=) |
| CA (1) | CA2832664C (https=) |
| DK (1) | DK2696882T3 (https=) |
| ES (1) | ES2535521T3 (https=) |
| IL (1) | IL228821A (https=) |
| PL (1) | PL2696882T3 (https=) |
| RU (1) | RU2605288C2 (https=) |
| SE (1) | SE536091C2 (https=) |
| SG (1) | SG194074A1 (https=) |
| WO (1) | WO2012140216A1 (https=) |
| ZA (1) | ZA201308157B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2908840A1 (en) * | 2012-10-12 | 2015-08-26 | Peptonic Medical AB | Novel use of a composition comprising oxytocin |
| SG11201705591PA (en) | 2015-01-07 | 2017-08-30 | Trigemina Inc | Magnesium-containing oxytocin formulations and methods of use |
| US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9925233B2 (en) * | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US10849978B2 (en) | 2015-10-30 | 2020-12-01 | Teijin Pharma Limited | Pharmaceutical composition for administration to nasal mucosa |
| HUE070412T2 (hu) | 2016-04-12 | 2025-06-28 | Tonix Pharma Ltd | Magnézium tartalmú oxitocin készítmények és alkamazási eljárásaik |
| SE1750680A1 (en) * | 2017-05-30 | 2018-12-01 | Peptonic Medical Ab | Composition for treating or preventing climacteric disorders |
| TW202031283A (zh) * | 2018-09-20 | 2020-09-01 | 馬克 Ｃ 曼寧 | 穩定卡貝縮宮素鼻內製劑 |
| CN110169377B (zh) * | 2019-06-27 | 2021-09-14 | 浙江海洋大学 | 黄姑鱼的人工催产受精方法 |
| SE547797C2 (en) | 2023-09-25 | 2025-11-25 | Letavis Ab | Stimulation of plant germination |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3076797A (en) | 1957-07-22 | 1963-02-05 | Roussel Uclaf | Process of producing oxytocin and intermediates obtained thereby |
| US2938991A (en) | 1957-10-01 | 1960-05-31 | Candace Inc | Electric mattress pad |
| JPS61126014A (ja) * | 1984-11-22 | 1986-06-13 | Teijin Ltd | 経鼻投与用水性液剤 |
| SE9003712L (sv) | 1990-11-22 | 1992-01-07 | Kabi Pharmacia Ab | Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner |
| JP3179538B2 (ja) * | 1990-12-11 | 2001-06-25 | ノバルティス アクチエンゲゼルシャフト | 安定なヒトカルシトニンの水性溶液 |
| GB9326354D0 (en) | 1993-12-23 | 1994-02-23 | British Aerospace | Methods and apparatus for the testing,monitoring and improvement of manufacturing process effectiveness |
| SE9400918L (sv) * | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
| US5833647A (en) * | 1995-10-10 | 1998-11-10 | The Penn State Research Foundation | Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery |
| ATE247456T1 (de) | 1996-02-27 | 2003-09-15 | Teijin Ltd | Puderförmige zusammensetzung zur nasalen anwendung |
| SE9701161D0 (sv) | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use I |
| SE9701162D0 (sv) | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
| SE9701184D0 (sv) | 1997-04-01 | 1997-04-01 | Karolinska Innovations Ab | Substanser för att åstadkomma preferens och skapa acceptans |
| SE9803272D0 (sv) | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for cell regeneration |
| US20070032410A1 (en) * | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
| SE0001440D0 (sv) * | 2000-04-18 | 2000-04-18 | Entretech Medical Ab | A drug against climacteric disorders |
| SE0100684D0 (sv) | 2001-02-28 | 2001-02-28 | Kerstin Uvnaes Moberg | New subject-matter |
| SE0102184D0 (sv) | 2001-06-19 | 2001-06-19 | Uvnaes Moberg Kerstin | New subject-matter |
| SE0102910D0 (sv) | 2001-08-31 | 2001-08-31 | Moberg Kerstin Uvnaes | New use |
| JO2492B1 (en) * | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
| US7884076B2 (en) * | 2003-11-06 | 2011-02-08 | The Trustees Of Columbia University In The City Of New York | Multipeptide regimen for the treatment of autistic spectrum, behavioral, emotional and visceral inflammation/autoimmune disorders |
| AU2005267396B2 (en) * | 2004-06-24 | 2009-09-17 | Idexx Laboratories, Inc. | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| EP2248518B1 (en) * | 2009-04-17 | 2013-01-16 | Merz Pharma GmbH & Co. KGaA | Formulation for stabilizing proteins, peptides or mixtures thereof. |
-
2011
- 2011-04-14 SE SE1150324A patent/SE536091C2/sv not_active IP Right Cessation
-
2012
- 2012-04-13 JP JP2014504346A patent/JP5993442B2/ja not_active Expired - Fee Related
- 2012-04-13 CA CA2832664A patent/CA2832664C/en active Active
- 2012-04-13 ES ES12715932.5T patent/ES2535521T3/es active Active
- 2012-04-13 EP EP12715932.5A patent/EP2696882B1/en active Active
- 2012-04-13 RU RU2013147739/15A patent/RU2605288C2/ru active
- 2012-04-13 SG SG2013074133A patent/SG194074A1/en unknown
- 2012-04-13 KR KR1020137029608A patent/KR101940341B1/ko not_active Expired - Fee Related
- 2012-04-13 PL PL12715932T patent/PL2696882T3/pl unknown
- 2012-04-13 WO PCT/EP2012/056813 patent/WO2012140216A1/en not_active Ceased
- 2012-04-13 CN CN201280027310.1A patent/CN103596582B/zh not_active Expired - Fee Related
- 2012-04-13 BR BR112013026153A patent/BR112013026153A2/pt not_active Application Discontinuation
- 2012-04-13 AU AU2012241805A patent/AU2012241805B2/en not_active Ceased
- 2012-04-13 US US14/111,072 patent/US9034821B2/en active Active
- 2012-04-13 DK DK12715932T patent/DK2696882T3/en active
-
2013
- 2013-10-10 IL IL228821A patent/IL228821A/en active IP Right Grant
- 2013-10-31 ZA ZA2013/08157A patent/ZA201308157B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014515747A5 (https=) | ||
| JP2023017854A (ja) | インスリン分泌性ペプチドの安定な水性非経口医薬組成物 | |
| RU2013147739A (ru) | Фармацевтическая композиция | |
| JP5847793B2 (ja) | Ｖｉｐ断片および使用の方法 | |
| US20230107222A1 (en) | Engineered antimicrobial amphiphilic peptides and methods of use | |
| US11052132B2 (en) | Methods and compositions for treating cystic fibrosis | |
| JP2014012667A (ja) | ペプチドおよびその使用 | |
| WO2009033770A3 (en) | Calcitonin c-terminal flanking peptide for use as a therapeutic agent | |
| JP2019214610A (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| CN102068685A (zh) | 一种特利加压素制剂及其制备方法 | |
| WO2014142102A1 (ja) | 液体水性組成物 | |
| JP2010517987A (ja) | 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用 | |
| AU2018353935B2 (en) | A functional polypeptide and its application thereof in preparing medicament for preventing and treating pulmonary fibrosis | |
| AU2023204392A1 (en) | Cyclic prosaposin peptides and uses thereof | |
| JP2020511494A (ja) | Ｎｐｒａアゴニスト、組成物およびその使用 | |
| CA3229783A1 (en) | Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions | |
| Dewachter et al. | New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation | |
| Yu et al. | The novel peptide PACAP-TAT with enhanced traversing ability attenuates the severe lung injury induced by repeated smoke inhalation | |
| CN115724919B (zh) | 强效抑制艾滋病病毒及其耐药毒株的新型膜融合抑制剂及其药物用途 | |
| EP2908840A1 (en) | Novel use of a composition comprising oxytocin | |
| US20240115654A1 (en) | Intravenous administration of engineered antimicrobial amphiphilic peptides | |
| WO2017149098A1 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| WO2021094983A1 (en) | Polypeptides related to hmgb1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof | |
| Zhang et al. | Cyclization-Based Optimization of the Antimicrobial Peptide YD Yields a Nanomolar Inhibitor of Pulmonary Fibrosis | |
| Rennard et al. | Efficacy and Safety of the Novel, Long-Acting Antimuscarinic, Aclidinium Bromide, in COPD Patients in a Phase III Study: ACCLAIM/COPD II. |